Health Care Up Slightly As Amgen Rallies -- Health Care Roundup

Health-care companies rose slightly, as traders bet the sector was better positioned than most for rising inflation and interest rates.

Amgen shares rallied after analysts at brokerage Morgan Stanley boosted their rating on the biotech concern, citing potential for an obesity drug.

Albireo Pharma rose after it received Food and Drug Administration approval to use its medication Bylvay as a treatment for a rare liver condition.

 Write to Rob Curran at [e-mail] 

(END) Dow Jones Newswires

10-11-22 1709ET